|
Powered by Cell Signaling Technology |
Site Information |
---|
REIAQDFktDLRFQS SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 459011 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on biological processes: |
References | |
---|---|
Greenway J, et al. (2020) Profiling of Histone Modifications Reveals Epigenomic Dynamics During Abdominal Aortic Aneurysm Formation in Mouse Models. Front Cardiovasc Med 7, 595011
33195484 Curated Info |
|
Sidoli S, et al. (2015) Sequential Window Acquisition of all Theoretical Mass Spectra (SWATH) Analysis for Characterization and Quantification of Histone Post-translational Modifications. Mol Cell Proteomics 14, 2420-8
25636311 Curated Info |
|
Wang CM, et al. (2010) Identification of histone methylation multiplicities patterns in the brain of senescence-accelerated prone mouse 8. Biogerontology 11, 87-102
19434510 Curated Info |
|
Tweedie-Cullen RY, Reck JM, Mansuy IM (2009) Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J Proteome Res 8, 4966-82
19737024 Curated Info |
|
Zhou J (2008) CST Curation Set: 4211; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K
Curated Info |
|
Zhou J (2008) CST Curation Set: 4212; Year: 2008; Biosample/Treatment: tissue, brain, embryonic/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K
Curated Info |
|
Zhou J (2008) CST Curation Set: 4213; Year: 2008; Biosample/Treatment: tissue, heart/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K
Curated Info |
|
Zhou J (2008) CST Curation Set: 4214; Year: 2008; Biosample/Treatment: tissue, liver/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K
Curated Info |
|
Garcia BA, et al. (2007) Organismal differences in post-translational modifications in histones H3 and H4. J Biol Chem 282, 7641-55
17194708 Curated Info |
|
Cocklin RR, Wang M (2003) Identification of methylation and acetylation sites on mouse histone H3 using matrix-assisted laser desorption/ionization time-of-flight and nanoelectrospray ionization tandem mass spectrometry. J Protein Chem 22, 327-34
13678296 Curated Info |
|
Ng HH, et al. (2003) Lysine-79 of histone H3 is hypomethylated at silenced loci in yeast and mammalian cells: a potential mechanism for position-effect variegation. Proc Natl Acad Sci U S A 100, 1820-5
12574507 Curated Info |